{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:02:49Z","timestamp":1790388169366,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03487-2","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T09:49:39Z","timestamp":1731318579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Safety comparison of single-donor and pooled fecal microbiota transfer product preparation in ulcerative colitis: systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Bastien","family":"Laperrousaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Levast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Nancey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dechelotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lehert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"1","key":"3487_CR1","doi-asserted-by":"publisher","first-page":"1847976","DOI":"10.1080\/19490976.2020.1847976","volume":"12","author":"H Yang","year":"2020","unstructured":"Yang H, Mirsepasi-Lauridsen HC, Struve C, et al. Ulcerative Colitis associated E. coli pathobionts potentiate colitis in susceptible hosts. Gut Microbes. 2020;12(1):1847976.","journal-title":"Gut Microbes"},{"issue":"10075","key":"3487_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial. The Lancet. 2017;389(10075):1218\u201328.","journal-title":"Lancet"},{"issue":"30","key":"3487_CR3","doi-asserted-by":"publisher","first-page":"e29790","DOI":"10.1097\/MD.0000000000029790","volume":"101","author":"T Huang","year":"2022","unstructured":"Huang T, Xu J, Wang M, et al. An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis. Medicine. 2022;101(30):e29790.","journal-title":"Medicine"},{"issue":"14","key":"3487_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.21037\/atm-22-3236","volume":"10","author":"Z-J Wei","year":"2022","unstructured":"Wei Z-J, Dong H-B, Ren Y-T, Jiang B. Efficacy and safety of fecal microbiota transplantation for the induction of remission in active ulcerative colitis: A systematic review and meta-analysis of randomized controlled trials. Ann Transl Med. 2022;10(14):802\u2013802.","journal-title":"Ann Transl Med"},{"issue":"5","key":"3487_CR5","doi-asserted-by":"publisher","first-page":"e00568","DOI":"10.14309\/ctg.0000000000000568","volume":"14","author":"B Levast","year":"2023","unstructured":"Levast B, Fontaine M, Nancey S, Dechelotte P, Dor\u00e9 J, Lehert P. Single-donor and pooling strategies for fecal microbiota transfer product preparation in ulcerative colitis: A systematic review and meta-analysis. Clin Transl Gastroenterol. 2023;14(5):e00568.","journal-title":"Clin Transl Gastroenterol."},{"key":"3487_CR6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ."},{"issue":"12","key":"3487_CR7","doi-asserted-by":"publisher","first-page":"zsy185","DOI":"10.1093\/sleep\/zsy185","volume":"41","author":"P Lehert","year":"2018","unstructured":"Lehert P, Falissard B. Multiple treatment comparison in narcolepsy: a network meta-analysis. Sleep. 2018;41(12):zsy185. https:\/\/doi.org\/10.1093\/sleep\/zsy185.\u00a0PMID: 30239930; PMCID: PMC6289237.","journal-title":"Sleep."},{"issue":"1","key":"3487_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0377-2217(86)90167-0","volume":"26","author":"D Bouyssou","year":"1986","unstructured":"Bouyssou D. Some remarks on the notion of compensation in Multiple criterion Decision Making MCDM. Eur J Oper Res. 1986;26(1):150\u201360.","journal-title":"Eur J Oper Res"},{"issue":"4","key":"3487_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"3487_CR10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"25","key":"3487_CR11","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1002\/sim.6236","volume":"33","author":"G Rucker","year":"2014","unstructured":"Rucker G, Schwarzer G. Reduce dimension or reduce weights? Comparing two approaches to multi-arm studies in network meta-analysis. Stat Med. 2014;33(25):4353\u201369.","journal-title":"Stat Med"},{"issue":"16","key":"3487_CR12","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/sim.1201","volume":"21","author":"T Lumley","year":"2002","unstructured":"Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002;21(16):2313\u201324.","journal-title":"Stat Med"},{"issue":"2","key":"3487_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: Many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80\u201397.","journal-title":"Res Synth Methods"},{"issue":"4","key":"3487_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jrsm.1058","volume":"3","author":"G Rucker","year":"2012","unstructured":"Rucker G. Network meta-analysis, electrical networks and graph theory. Res Synth Methods. 2012;3(4):312\u201324.","journal-title":"Res Synth Methods"},{"issue":"1","key":"3487_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G Rucker","year":"2015","unstructured":"Rucker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15(1):58.","journal-title":"BMC Med Res Methodol"},{"key":"3487_CR16","unstructured":"Rucker G, Schwarzer G, Krahn U, et al. Package Netmeta Version 0.8\u20130, Network Meta-Analysis Using Frequentist Methods. R Library, 2015, pp 23\u201334. Repository CRAN 06\u201326."},{"issue":"4","key":"3487_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"3487_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407\u201315.","journal-title":"J Clin Epidemiol"},{"key":"3487_CR19","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, et al. Grade handbook: Introduction to GRADE Handbook. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed 21 Feb 2024."},{"key":"3487_CR20","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. www.training.cochrane.org\/handbook. Cochrane 2021. Accessed 21 Feb 2024."},{"key":"3487_CR21","unstructured":"Subhadra B. Devices, Systems and Methods for the Production of Humanized Gut Commensal Microbiota. United States patent 2018\/0030403 A1."},{"issue":"12","key":"3487_CR22","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","volume":"71","author":"S Kedia","year":"2022","unstructured":"Kedia S, Virmani S, Vuyyuru SK, et al. Faecal microbiota transplantation with anti-inflammatory diet (FMT-aid) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: A randomised controlled trial. Gut. 2022;71(12):2401\u201313.","journal-title":"Gut."},{"issue":"1","key":"3487_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110\u20138.e4.","journal-title":"Gastroenterology"},{"issue":"2","key":"3487_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","volume":"7","author":"C Haifer","year":"2022","unstructured":"Haifer C, Paramsothy S, Kaakoush NO, et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): A randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7(2):141\u201351.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"3487_CR25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/ecco-jcc\/jjz060","volume":"13","author":"A Sood","year":"2019","unstructured":"Sood A, Mahajan R, Singh A, et al. Role of faecal microbiota transplantation for maintenance of remission in patients with ulcerative colitis: A pilot study. J Crohn\u2019s Colitis. 2019;13(10):1311\u20137.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"3487_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP, Hughes PA, Waters O, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: A randomized clinical trial. JAMA. 2019;321(2):156\u201364.","journal-title":"JAMA"},{"issue":"1","key":"3487_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102\u20139.e6.","journal-title":"Gastroenterology"},{"issue":"1","key":"3487_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","volume":"21","author":"JW Crothers","year":"2021","unstructured":"Crothers JW, Chu ND, Nguyen LTT, et al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: Results of a single-center, prospective, randomized pilot study. BMC Gastroenterol. 2021;21(1):281.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"3487_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1053\/j.gastro.2021.04.067","volume":"161","author":"N Pai","year":"2021","unstructured":"Pai N, Popov J, Hill L, et al. Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: Lessons, limitations, and future prospects. Gastroenterology. 2021;161(2):388\u201393.e3.","journal-title":"Gastroenterology"},{"issue":"13","key":"3487_CR30","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.3390\/jcm10132753","volume":"10","author":"J B\u0159ezina","year":"2021","unstructured":"B\u0159ezina J, Bajer L, Wohl P, et al. Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitisresults of a randomized controlled trial. J Clin Med. 2021;10(13):2753.","journal-title":"J Clin Med"},{"issue":"3","key":"3487_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjab165","volume":"16","author":"C Sarbagili Shabat","year":"2022","unstructured":"Sarbagili Shabat C, Scaldaferri F, Zittan E, et al. Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomised controlled trial. J Crohn\u2019s Colitis. 2022;16(3):369\u201378.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3487_CR32","doi-asserted-by":"publisher","first-page":"S278","DOI":"10.1093\/ecco-jcc\/jju027.517","volume":"9","author":"F Scaldaferri","year":"2015","unstructured":"Scaldaferri F, Pecere S, Bruno G, et al. An open-label, pilot study to assess feasibility and safety of fecal microbiota transplantation in patients with mild-moderate ulcerative colitis: Preliminary results. J Crohn\u2019s Colitis. 2015;9:S278.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3487_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-med-111717-122956","volume":"70","author":"RE Ooijevaar","year":"2019","unstructured":"Ooijevaar RE, Terveer EM, Verspaget HW, Kuijper EJ, Keller JJ. Clinical application and potential of fecal microbiota transplantation. Annu Rev Med. 2019;70:335\u201351.","journal-title":"Annu Rev Med."},{"issue":"1","key":"3487_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apt.16148","volume":"53","author":"C Marcella","year":"2021","unstructured":"Marcella C, Cui B, Kelly CR, Ianiro G, Cammarota G, Zhang F. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment Pharmacol Ther janv. 2021;53(1):33\u201342.","journal-title":"Aliment Pharmacol Ther janv"},{"issue":"1","key":"3487_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/cid\/civ247","volume":"61","author":"M Baxter","year":"2015","unstructured":"Baxter M, Ahmad T, Colville A, Sheridan R. Fatal aspiration pneumonia as a complication of fecal microbiota transplant. Clin Infect Dis. 2015;61(1):136\u20137.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"3487_CR36","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.infpip.2020.100069","volume":"2","author":"B Merrick","year":"2020","unstructured":"Merrick B, Allen L, Masirah M, Zain N, Forbes B, Shawcross DL, Goldenberg SD. Regulation, risk and safety of faecal microbiota transplant. Infect Prev Pract. 2020;2(3):100069.","journal-title":"Infect Prev Pract."},{"issue":"2","key":"3487_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jhin.2015.10.024","volume":"92","author":"M Baxter","year":"2016","unstructured":"Baxter M, Colville A. Adverse events in faecal microbiota transplant: a review of the literature. J Hosp Infect fevr. 2016;92(2):117\u201327.","journal-title":"J Hosp Infect fevr"},{"issue":"2","key":"3487_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/diseases8020009","volume":"8","author":"C Nicco","year":"2020","unstructured":"Nicco C, Paule A, Konturek P, et al. From donor to patient: collection, preparation and cryopreservation of fecal samples for fecal microbiota transplantation. Diseases. 2020;8(2):9.","journal-title":"Diseases"},{"issue":"1","key":"3487_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/apt.14387","volume":"47","author":"P Kump","year":"2018","unstructured":"Kump P, Wurm P, Gr\u00f6chenig HP, et al. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Aliment Pharmacol Ther. 2018;47(1):67\u201377.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3487_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/ecco-jcc\/jjv203","volume":"10","author":"S Vermeire","year":"2015","unstructured":"Vermeire S, Joossens M, Verbeke K, et al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohn\u2019s Colitis. 2015;10(4):387\u201394.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3487_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcimb.2019.00002","volume":"9","author":"BC Wilson","year":"2019","unstructured":"Wilson BC, Vatanen T, Cutfield WS, O\u2019Sullivan JM. The super-donor phenomenon in fecal microbiota transplantation. Front Cell Infect Microbiol. 2019;9:2.","journal-title":"Front Cell Infect Microbiol."},{"issue":"1","key":"3487_CR42","doi-asserted-by":"publisher","first-page":"e0163956","DOI":"10.1371\/journal.pone.0163956","volume":"12","author":"A Kazerouni","year":"2017","unstructured":"Kazerouni A, Wein LM. Exploring the efficacy of pooled stools in fecal microbiota transplantation for microbiota-associated chronic diseases. PLoS ONE. 2017J 9;12(1):e0163956.","journal-title":"PLoS ONE"},{"issue":"5","key":"3487_CR43","doi-asserted-by":"publisher","first-page":"e0001624","DOI":"10.1128\/aem.00016-24","volume":"90","author":"J Reygner","year":"2024","unstructured":"Reygner J, Delannoy J, Barba-Goudiaby MT, Gasc C, Levast B, Gaschet E, et al. Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine models. Appl Environ Microbiol. 2024;90(5):e0001624.","journal-title":"Appl Environ Microbiol."},{"key":"3487_CR44","doi-asserted-by":"publisher","first-page":"102111","DOI":"10.1016\/j.eclinm.2023.102111","volume":"62","author":"F Malard","year":"2023","unstructured":"Malard F, Loschi M, Huynh A, Cluzeau T, Guenounou S, Legrand F, et al. Pooled allogeneic faecal microbiota MAAT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: A single-arm, Multicentre phase 2 trial. eClinicalMedicine. 2023;62:102111.","journal-title":"eClinicalMedicine."},{"key":"3487_CR45","doi-asserted-by":"publisher","first-page":"104088","DOI":"10.1016\/j.ebiom.2022.104088","volume":"81","author":"NP Rees","year":"2022","unstructured":"Rees NP, Shaheen W, Quince C, et al. Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis. EBioMedicine. 2022;81:104088.","journal-title":"EBioMedicine"},{"issue":"6","key":"3487_CR46","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3390\/jcm9061650","volume":"9","author":"K Okahara","year":"2020","unstructured":"Okahara K, Ishikawa D, Nomura K, et al. Matching between donors and ulcerative colitis patients is important for long-term maintenance after fecal microbiota transplantation. J Clin Med. 2020;9(6):1650.","journal-title":"J Clin Med"},{"issue":"7488","key":"3487_CR47","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/506290a","volume":"506","author":"MB Smith","year":"2014","unstructured":"Smith MB, Kelly C, Alm EJ. Policy: How to regulate faecal transplants. Nature. 2014;506(7488):290\u20131.","journal-title":"Nature"},{"issue":"9","key":"3487_CR48","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/1751-7915.14074","volume":"15","author":"G Lu","year":"2022","unstructured":"Lu G, Wang W, Li P, Wen Q, Cui B, Zhang F. Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Microb Biotechnol. 2022;15(9):2439\u201349.","journal-title":"Microb Biotechnol"},{"issue":"4","key":"3487_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","volume":"11","author":"T Zhang","year":"2020","unstructured":"Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, et al. Washed microbiota transplantation vs. manual fecal microbiota transplantation: Clinical findings, animal studies and in vitro screening. Protein and Cell. 2020;11(4):251\u201366. https:\/\/doi.org\/10.1007\/s13238-019-00684-8.","journal-title":"Protein and Cell."},{"issue":"6","key":"3487_CR50","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/nu11061415","volume":"11","author":"M El-Salhy","year":"2019","unstructured":"El-Salhy M, Hausken T, Gunnar HJ. Increasing the dose and\/or repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). Nutrients. 2019;11(6):1415.","journal-title":"Nutrients"},{"issue":"20","key":"3487_CR51","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/jama.2017.17077","volume":"318","author":"D Kao","year":"2017","unstructured":"Kao D, Roach B, Silva M, Beck P, Rioux K, Kaplan GG, Chang HJ, Coward S, Goodman KJ, Xu H, Madsen K, Mason A, Wong GK, Jovel J, Patterson J, Louie T. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: a randomized clinical trial. JAMA. 2017;318(20):1985\u201393.","journal-title":"JAMA"},{"issue":"7109","key":"3487_CR52","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03487-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03487-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03487-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T02:04:25Z","timestamp":1731463465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03487-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3487"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03487-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was funded by MaaT Pharma, France; . An unconditional grant was provided to the authors, and MaaT Pharma was not involved in writing the protocol, statistical plan, or discussion of results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}